Advertisement

Topics

UroGenRA - Genitourinary cancer array - Biotech, Pharma and Life Science Channel

01:47 EST 24th January 2019 | BioPortfolio

UroGenRA is a CGI custom-designed oligonucleotide array for implementation within a clinical laboratory as an array CGH-based diagnostic/prognostic tool for kidney, prostate, and bladder cancers. It was designed to detect gains and losses that frequently occur in these three cancer types and that have the potential to differentially diagnose and/or stratify patients to assist and guide clinical management. For kidney cancer, it is specifically designed to classify tumors into the four main types (three malignant, one benign) critical at several levels in patient management: diagnosis of image-guided needle biopsies of small incidentally discovered kidney masses providing rationale for surgical/non-surgical management,  diagnosis in patients with larger neoplasms to stratify for risks of local or regionally advanced disease that can be factored in to treatment selection recommendations (i.e., extent of surgical intervention, less invasive options or ablation), in those with metastatic disease, where drug trials are currently based on post-surgical tumor diagnosis, and potentially in the diagnosis of the so-called morphologically “unclassified” renal cancers. Additionally within the predominant subtype, clear cell renal cell carcinoma, prognostication is feasible based on the presence/absence of gain and loss of certain genomic regions. For prostate cancer, UroGenRA, has the potential to assess prostate core/needle biopsy genomic variability, to identify biomarker for inclusion in nomograms for assessment of risk of biochemical recurrence, to assess radiocurability and treatment options for intermediate risk patients, and to explore the genomic aberrations of circulating tumor cells. For bladder cancer, UroGenRA has application in identifying tumors most likely to recur, and of muscle-invasive lesions those most likely to benefit from treatment.

Source: http://cancergenetics.com/cgi-research/cgh-microarray/ UroGenRA is a Registered Trademark of CGI

PubMed Articles [14526 Associated PubMed Articles listed on BioPortfolio]

Effect of trail C1595T variant and gene expression on the pathogenesis of non-small cell lung cancer.

It is known that disorders in apoptosis function play an important role in the pathogenesis of many types of cancer, including lung cancer. Tumor necrosis factor related apoptosis inducing ligand (TRA...

Erratum.

A Maximum Likelihood Approach for Depth Field Estimation Based on Epipolar Plane Images.

In this paper, a multi-resolution method for depth estimation from dense image arrays is presented. Recent progress in consumer electronics has enabled the development of low cost hand-held plenoptic ...

Screening of Mangifera indica L. functional content using PCA and neural networks (ANN).

A method using reversed-phase high-performance liquid chromatography with diode array detection (HPLC-DAD) was applied after extraction with acidified methanol, to determine 12 bioactive phenolic comp...

Multivariate analysis of the composition of bioactive in tea of the species Camellia sinensis.

This study deals with the development of a separation and quantification method by high performance liquid chromatography with a diode array detector (HPLC- DAD), for the determination of phenolic aci...

Investigation of plasticizer aggregation problem in casein based biopolymer using chemical imaging.

This work aims to investigate the emergence of aggregates caused by redundant plasticizers in the protein matrix of casein based biopolymers using chemical imaging techniques. Near infrared (NIR) imag...

Nanocone-based plasmonic metamaterials.

Metamaterials and metasurfaces provide unprecedented opportunities for designing light-matter interactions. Optical properties of hyperbolic metamaterials with meta-atoms based on plasmonic nanorods, ...

The 15th Annual Warren K. Sinclair Keynote Address-Jus•ti•fied and Com•men•su•rate.

When patients are exposed to ionizing radiation for medical diagnosis or treatment, the procedure being performed should be justified, and the amount of ionizing radiation used should be commensurate ...

Uses of Effective Dose: The Good, the Bad, and the Future.

Effective dose (E) is a risk-adjusted dosimetric quantity developed by the International Commission on Radiological Protection. It is a key metric for practical management of the risk of stochastic he...

Radiopharmaceutical Therapy.

Radiopharmaceutical therapy involves the use of radionuclides that are either conjugated to tumor-targeting agents (e.g., nanoscale constructs, antibodies, peptides, and small molecules) or that conce...

News Articles [12896 Associated News Articles listed on BioPortfolio]

STAT Plus: “Existing approaches to managing the prices of cancer medicines have not resulted in outcomes that meet policy and economic objectives." https://buff.ly/2DvI37E 

STAT Plus: “Existing approaches to managing the prices of cancer medicines have not resulted in outcomes that meet policy and economic objectives." https://buff.ly/2DvI37E 

ADXS Cervical Cancer Trial Put On Hold, GIS Recalls Flour, NCNA, URGN Slump

Today's Daily Dose brings you news about stock offerings of Ohr Pharma, NuCana, UroGen; General Mills' recall of Gold Medal Unbleached Flour; partial clinical hold on Advaxis' cervical cancer trial; a...

A Silicon Valley startup wants to offer precision medicine to help treat dogs with #cancer. https://buff.ly/2FSuy3c 

A Silicon Valley startup wants to offer precision medicine to help treat dogs with #cancer. https://buff.ly/2FSuy3c 

. @SBPdiscovery researchers detail how a targeted therapy shrinks tumors in mice with a form of pediatric #brain #Cancer known as medulloblastoma: http://ow.ly/UQcH30nqcA9 

. @SBPdiscovery researchers detail how a targeted therapy shrinks tumors in mice with a form of pediatric #brain #Cancer known as medulloblastoma: http://ow.ly/UQcH30nqcA9 

Free lung cancer screening program builds valuable relationships with patients

(Medical College of Georgia at Augusta University) A free, simple screening for lung cancer can save a patient money, while building a healthy relationship for any medical needs they may have in the f...

Cartherics and ToolGen sign a deal on CAR-T therapy

Australia’s Cartherics and Seoul-based ToolGen have teamed up to bring innovative immunotherapies for cancer a step closer to reality. The deal will allow Cartherics to share its expertise in immun...

How a team at @BostonChildrens is turning to urine to search for signs of #cancer. https://buff.ly/2R6EHvb 

How a team at @BostonChildrens is turning to urine to search for signs of #cancer. https://buff.ly/2R6EHvb 

. @HopkinsMedicine researchers report on a potentially simple and inexpensive screening for esophageal #Cancer: http://ow.ly/yndq30nqcoi 

. @HopkinsMedicine researchers report on a potentially simple and inexpensive screening for esophageal #Cancer: http://ow.ly/yndq30nqcoi 

Oxford Gene Technology Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryOxford Gene Technology Ltd OGT is a provider of genetics research solutions. The company's products include fish probes, custom cancer panels, custom AML panel, custom breast cancer panel, cust...

Alphabet sees progress in breast cancer care with AI

Ruth Porat, chief executive officer of Google parent company Alphabet, said the company is making progress in breast cancer care thanks to AI, according to a report by CNBC.

Companies [815 Associated Companies listed on BioPortfolio]

Rebound Therapeutics

Rebound has progressed rapidly over the past 18 months, having developed a unique array of devices to improve the procedural and clinical outcomes of many minimally invasive surgi...

STEMCELL Technologies Inc

STEMCELL Technologies supports life sciences research with more than 2,500 specialized reagents, tools, and services. We offer high quality cell culture media, cell separat...

ImmunSYS, Inc.

ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of innovative cancer immunotherapy products to improve the lives of patients with late-sta...

KIOSK Information Systems

As the market leader in self-service solutions, KIOSK provides proven expertise in design engineering, application development, integration, manufacturing, field support, and mana...

AT&T Inc.

AT&T Inc. (NYSE: T) is a premier communications holding company. Its subsidiaries and affiliates - AT&T operating companies - are the providers of AT&T services in the United States and around the wor...

Forbius

Forbius is a clinical stage company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases. Forbius’ medicines are designed to radically ...

Propanc Biopharma, Inc.

Propanc Biopharma, Inc. (the "Company") is a biopharmaceutical company developing new cancer treatments initially for patients suffering from pancreatic, ovarian and colorectal ca...

OncoImmunity

OncoImmunity is a machine-learning company offering a proprietary technology to address the key knowledge gaps in the prediction of bone fide immunogenic neoantigens for person...

California Breast Cancer Research Program

Checkmate Pharmaceuticals Inc.

Checkmate Pharmaceuticals is a clinical stage company that is leveraging its expertise in the field of CpG oligonucleotides to discover and develop immunotherapies designed to inc...

Clinical Trials [9208 Associated Clinical Trials listed on BioPortfolio]

Anxiety and Distress Levels in Women With Suspected Endometrial Cancer

Patients attending the rapid access gynaecology clinic with a suspicion of endometrial cancer are understandably nervous. Few studies have quantified anxiety and distress of patients in th...

Acceptability and Efficacy of Self-sampling for Cervical Cancer Screening: A Pilot Study

In Singapore, the current cervical cancer screening uptake among women in Singapore has remained at low 50% since its introduction in 2004. It has been widely reported that under-screened ...

Epigenetic Modulation of the immunE Response in GastrointEstinal Cancers (EMERGE)

A multicenter phase II non-randomised trial assessing the efficacy of domatinostat (4SC-202) plus avelumab in patients with GI cancer

Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection

This early phase I trial studies how well nivolumab and yttrium-90 work in treating patients with liver cancer who are undergoing surgical resection. Immunotherapy with monoclonal antibodi...

Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases

This study is to find out if administration of stereotactic radiosurgery (SRS) given after Nivolumab will improve overall response rate/anti-tumor activity in patients with metastatic brea...

Community-based Intervention for Cervical Cancer Screening Uptake in Nepal

Cervical cancer is the major cause of cancer deaths among women in Nepal. Screening is one of the most effective tools for early diagnosis, prevention and treatment. However, skilled healt...

Efficacy and Safety of SCT200 in Patients With Advanced Squamous Non-small Cell Lung Cancer

The purpose of this study is to evaluate the efficacy and safety of recombinant anti-EGFR monoclonal antibody(SCT200)in patients with advanced squamous non-small cell lung cancer treat...

Untire Application Intervention in Reducing Cancer-Related Fatigue in Cancer Patients and Survivors

This trial studies how well Untire application intervention works in reducing cancer-related fatigue in cancer patients and survivors.The Untire application focuses on themes that have bee...

Film Array Gastrointestinal Panel Compared to Usual Care for ED Evaluation of Infectious Diarrhea

This research study will test a laboratory test called Film-Array Gastrointestinal (GI) Panel. This GI Panel is a test that can identify the bacteria or viruses that may cause diarrhea. Th...

A Pilot Study of 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer

The objective of the study is to evaluate 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for biopsy guidance in patients with suspected prostate cancer.

Medical and Biotech [MESH] Definitions

The simultaneous analysis of multiple samples of TISSUES or CELLS from BIOPSY or in vitro culture that have been arranged in an array format on slides or microchips.

A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)

A deoxycytidine derivative and fluorouracil PRODRUG that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of COLON CANCER; BREAST CANCER and GASTRIC CANCER.

A genus of gram-negative, aerobic, coccoid bacteria whose organisms are part of the normal flora of the oropharynx, nasopharynx, and genitourinary tract. Some species are primary pathogens for humans.

A contiguous gene syndrome associated with hemizygous deletions of chromosome region 11p13. The condition is marked by the combination of WILMS TUMOR; ANIRIDIA; GENITOURINARY ABNORMALITIES; and MENTAL RETARDATION.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Renal disease
Chronic kidney disease (CKD), also known as chronic renal disease, is a progressive loss in renal function over a period of months or years. The symptoms of worsening kidney function are non-specific, and might include feeling generally unwell and experi...